Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Protein misfolding and aggregation in Alzheimer's disease and type 2 diabetes mellitus.
Ashraf GM, Greig NH, Khan TA, Hassan I, Tabrez S, Shakil S, Sheikh IA, Zaidi SK, Akram M, Jabir NR, Firoz CK, Naeem A, Alhazza IM, Damanhouri GA, Kamal MA.
CNS Neurol Disord Drug Targets. 2014;13(7):1280-93.
Similar articles
Proteomics approaches to understand linkage between Alzheimer's disease and type 2 diabetes mellitus.
Mirza Z, Ali A, Ashraf GM, Kamal MA, Abuzenadah AM, Choudhary AG, Damanhouri GA, Sheikh IA.
CNS Neurol Disord Drug Targets. 2014 Mar;13(2):213-25. Review.
Linking Alzheimer's disease and type 2 diabetes mellitus via aberrant insulin signaling and inflammation.
Kamal MA, Priyamvada S, Anbazhagan AN, Jabir NR, Tabrez S, Greig NH.
CNS Neurol Disord Drug Targets. 2014 Mar;13(2):338-46. Review.
Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus.
Mushtaq G, Greig NH, Khan JA, Kamal MA.
CNS Neurol Disord Drug Targets. 2014;13(8):1432-9. Review.
Alzheimer's and type 2 diabetes treatment via common enzyme targeting.
Jabir NR, Kamal MA, Abuzenadah AM, Gan SH, Alama MN, Baeesa SS, Tabrez S.
CNS Neurol Disord Drug Targets. 2014 Mar;13(2):299-304. Review.
Genomic linkage between Alzheimer's disease and type 2 diabetes.
Nedjadi T, Haque A, Alam Q, Gan SH, Chaudhary AG, Abuzenadah AM, Damanhouri GA, Kamal MA.
CNS Neurol Disord Drug Targets. 2014 Mar;13(2):203-12. Review.
A synopsis on the role of tyrosine hydroxylase in Parkinson's disease.
Tabrez S, Jabir NR, Shakil S, Greig NH, Alam Q, Abuzenadah AM, Damanhouri GA, Kamal MA.
CNS Neurol Disord Drug Targets. 2012 Jun 1;11(4):395-409. Review.
Current view from Alzheimer disease to type 2 diabetes mellitus.
Rasool M, Malik A, Qazi AM, Sheikh IA, Manan A, Shaheen S, Qazi MH, Chaudhary AG, Abuzenadah AM, Asif M, Alqahtani MH, Iqbal Z, Shaik MM, Gan SH, Kamal MA.
CNS Neurol Disord Drug Targets. 2014 Apr;13(3):533-42. Review.
Synopsis on the linkage of Alzheimer's and Parkinson's disease with chronic diseases.
Jabir NR, Firoz CK, Baeesa SS, Ashraf GM, Akhtar S, Kamal W, Kamal MA, Tabrez S.
CNS Neurosci Ther. 2015 Jan;21(1):1-7. doi: 10.1111/cns.12344. Epub 2014 Nov 15. Review.
A nanotechnological approach to the management of Alzheimer disease and type 2 diabetes.
Alam Q, ZubairAlam M, Karim S, Gan SH, Kamal MA, Jiman-Fatani A, Damanhouri GA, Abuzenadah AM, Chaudhary AG, Haque A.
CNS Neurol Disord Drug Targets. 2014 Apr;13(3):478-86. Review.
Current challenges to overcome in the management of type 2 diabetes mellitus and associated neurological disorders.
Khan NM, Ahmad A, Tiwari RK, Kamal MA, Mushtaq G, Ashraf GM.
CNS Neurol Disord Drug Targets. 2014;13(8):1440-57.
How do periodontal infections affect the onset and progression of Alzheimer's disease?
Shaik MM, Ahmad S, Gan SH, Abuzenadah AM, Ahmad E, Tabrez S, Ahmed F, Kamal MA.
CNS Neurol Disord Drug Targets. 2014 Apr;13(3):460-6. Review.
An overview on potential neuroprotective compounds for management of Alzheimer's disease.
Sheikh IA, Ali R, Dar TA, Kamal MA.
CNS Neurol Disord Drug Targets. 2012 Dec;11(8):1006-11. Review.
Alzheimer's disease and type 2 diabetes: exploring the association to obesity and tyrosine hydroxylase.
Priyadarshini M, Kamal MA, Greig NH, Reale M, Abuzenadah AM, Chaudhary AG, Damanhouri GA.
CNS Neurol Disord Drug Targets. 2012 Jun 1;11(4):482-9. Review.
Comparative study of non-high density lipoproteins cholesterol level and lipid profile in pre-diabetic and diabetic patients.
Banu S, Jabir NR, Manjunath NC, Firoz CK, Kamal MA, Khan MS, Tabrez S.
CNS Neurol Disord Drug Targets. 2014 Apr;13(3):402-7.
Recent Updates on the Association Between Alzheimer's Disease and Vascular Dementia.
Ashraf GM, Chibber S, Mohammad, Zaidi SK, Tabrez S, Ahmad A, Shakil S, Mushtaq G, Baeesa SS, Kamal MA.
Med Chem. 2016;12(3):226-37. Review.
Interaction of human brain acetylcholinesterase with cyclophosphamide: a molecular modeling and docking study.
Shakil S, Khan R, Tabrez S, Alam Q, Jabir NR, Sulaiman MI, Greig NH, Kamal MA.
CNS Neurol Disord Drug Targets. 2011 Nov;10(7):845-8.
Molecular interaction of the antineoplastic drug, methotrexate with human brain acetylcholinesterase: a docking study.
Shakil S, Kamal MA, Tabrez S, Abuzenadah AM, Chaudhary AG, Damanhouri GA.
CNS Neurol Disord Drug Targets. 2012 Mar;11(2):142-7.
Inhibition of Butyrylcholinesterase with Fluorobenzylcymserine, An Experimental Alzheimer's Drug Candidate: Validation of Enzoinformatics Results by Classical and Innovative Enzyme Kinetic Analyses.
Kamal MA, Shakil S, Nawaz MS, Yu QS, Tweedie D, Tan Y, Qu X, Greig NH.
CNS Neurol Disord Drug Targets. 2017;16(7):820-827. doi: 10.2174/1871527316666170207160606.
Current Update on Synopsis of miRNA Dysregulation in Neurological Disorders.
Kamal MA, Mushtaq G, Greig NH.
CNS Neurol Disord Drug Targets. 2015;14(4):492-501. Review.
Filters: Manage Filters